These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36341933)

  • 1. Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery.
    Shen D; Yu H; Wang L; Feng J; Zhang Q; Pan J; Han Y; Ni Z; Liang R; Uddin MA
    J Control Release; 2022 Dec; 352():527-539. PubMed ID: 36341933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Docking-Guided Design on Glucose-Responsive Nanoparticles for Microneedle Fabrication and "Three-Meal-per-Day" Blood-Glucose Regulation.
    Shen D; Yu H; Wang L; Wang Y; Hong Y; Li C
    ACS Appl Mater Interfaces; 2023 Jul; 15(26):31330-31343. PubMed ID: 37339143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte-Membrane-Enveloped Biomineralized Metal-Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery.
    He M; Yu P; Hu Y; Zhang J; He M; Nie C; Chu X
    ACS Appl Mater Interfaces; 2021 May; 13(17):19648-19659. PubMed ID: 33890785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycopolymer Nanoparticles with On-Demand Glucose-Responsive Insulin Delivery and Low-Hypoglycemia Risks for Type 1 Diabetic Treatment.
    Fu Y; Sun Y; Chen M; Xing W; Xu Y; Qian X; Zhu W
    Biomacromolecules; 2022 Mar; 23(3):1251-1258. PubMed ID: 35084834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.
    Wang J; Wang Z; Chen G; Wang Y; Ci T; Li H; Liu X; Zhou D; Kahkoska AR; Zhou Z; Meng H; Buse JB; Gu Z
    ACS Nano; 2021 Mar; 15(3):4294-4304. PubMed ID: 33685124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation.
    Fang Y; Wang Q; Lin X; Jin X; Yang D; Gao S; Wang X; Yang M; Shi K
    J Pharm Sci; 2019 Sep; 108(9):2994-3002. PubMed ID: 31047941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin.
    Rastogi R; Anand S; Koul V
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer.
    Sharma D; Singh J
    J Control Release; 2020 Jul; 323():161-178. PubMed ID: 32283211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Smart" Composite Microneedle Patch Stabilizes Glucagon and Prevents Nocturnal Hypoglycemia: Experimental Studies and Molecular Dynamics Simulation.
    Lu B; GhavamiNejad A; Liu JF; Li J; Mirzaie S; Giacca A; Wu XY
    ACS Appl Mater Interfaces; 2022 May; 14(18):20576-20590. PubMed ID: 35471922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
    J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, in vitro and in vivo evaluation of PLGA/Chitosan based nano-complex as a novel insulin delivery formulation.
    Mohammadpour F; Hadizadeh F; Tafaghodi M; Sadri K; Mohammadpour AH; Kalani MR; Gholami L; Mahmoudi A; Chamani J
    Int J Pharm; 2019 Dec; 572():118710. PubMed ID: 31629731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats.
    Salvioni L; Fiandra L; Del Curto MD; Mazzucchelli S; Allevi R; Truffi M; Sorrentino L; Santini B; Cerea M; Palugan L; Corsi F; Colombo M
    Pharmacol Res; 2016 Aug; 110():122-130. PubMed ID: 27181095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.
    Zhao X; Shi A; Ma Q; Yan X; Bian L; Zhang P; Wu J
    J Nanobiotechnology; 2021 Jun; 19(1):191. PubMed ID: 34176494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
    GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
    Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
    Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
    Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microgel encapsulated nanoparticles for glucose-responsive insulin delivery.
    Volpatti LR; Facklam AL; Cortinas AB; Lu YC; Matranga MA; MacIsaac C; Hill MC; Langer R; Anderson DG
    Biomaterials; 2021 Jan; 267():120458. PubMed ID: 33197650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles integrating natural and synthetic polymers for
    Hadiya S; Radwan R; Zakaria M; El-Sherif T; Hamad MA; Elsabahy M
    Pharm Dev Technol; 2021 Jan; 26(1):30-40. PubMed ID: 33019826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of superparamagnetic iron oxide nanoparticles on glucose homeostasis on type 2 diabetes experimental model.
    Ali LMA; Shaker SA; Pinol R; Millan A; Hanafy MY; Helmy MH; Kamel MA; Mahmoud SA
    Life Sci; 2020 Mar; 245():117361. PubMed ID: 32001268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice.
    Chai Z; Dong H; Sun X; Fan Y; Wang Y; Huang F
    Int J Biol Macromol; 2020 Sep; 159():640-647. PubMed ID: 32428589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.